A Green Tea Compound Shows Anti-SARS-CoV-2 Properties In Vitro

Home » What Tea Is Good For Covid » A Green Tea Compound Shows Anti-SARS-CoV-2 Properties In Vitro

Maybe your like

A green tea compound shows anti-SARS-CoV-2 properties in vitro
  • Download PDF Copy
Editorial Checklist Revised Jocelyn Solis-MoreiraBy Jocelyn Solis-MoreiraMar 22 2021

Adding to its long list of health benefits, new research finds antiviral activity from green tea. In a new study, one of its ingredients, epigallocatechin gallate (EGCG), blocked severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) from binding to human angiotensin-converting enzyme 2 (ACE2) receptors and can subsequently prevent infection of human lung cells. This action was also observed in the SARS-CoV-2 variants of concern (VOC).

Green tea is one of the most consumed beverages in many countries across Asia. It has high anti-inflammatory and anti-oxidative properties that could help reduce the risk of developing severe COVID-19 symptoms.

Study: Evaluation of a new spike (S) protein based commercial immunoassay for the detection of anti-SARS-CoV-2 IgG. Image Credit: taa22 / Shutterstock Study: Evaluation of a new spike (S) protein based commercial immunoassay for the detection of anti-SARS-CoV-2 IgG. Image Credit: taa22 / Shutterstock

This news article was a review of a preliminary scientific report that had not undergone peer-review at the time of publication. Since its initial publication, the scientific report has now been peer reviewed and accepted for publication in a Scientific Journal. Links to the preliminary and peer-reviewed reports are available in the Sources section at the bottom of this article. View Sources

The researchers wrote:

Taken together, our data as well as the findings just reported by others[48-50] indicate the possibility that consumption of green tea or its active ingredient EGCG is beneficial for preventing or reducing SARS-CoV-2 transmission and infection…Given its low toxicity, antiinflammation, antioxidant, and anti-SARS-CoV-2 variant properties, use of GTB or EGCG is likely to minimize the SARS-CoV-2 spread, ameliorate symptoms and disease severity.”

The study “Epigallocatechin Gallate from Green Tea Effectively Blocks Infection of SARS-CoV-2 and New Variants by Inhibiting Spike Binding to ACE2 Receptor” is available as a preprint on the bioRxiv* server, while the article undergoes peer review.

Designing the research study

The team created several pseudoviruses that contained S proteins with a single mutation (K417N, E484K, N501Y, D614G) or with full-set mutations of the newly emerged variants (B.1.1.7, B.1.351, and B.1.429). They transfected the pseudoviruses into HEK293T-hACE2 cells. The wild-type S or D614G S was able to cause infection as observed by increased luciferase activity. Although, convalescent plasma of COVID-19 patients was successful in blocking both of these pseudoviruses.

The transfected cells showed little cytotoxicity to green tea beverages, indicating it was safe to use.

Viral inhibition caused by a green tea beverage

Green tea effectively prevented infection from the wild-type SARS-CoV-2 or D614G and the COVID-19 variants B.1.429 found in California and B.1.351 found in South Africa — in a dose-dependent manner. Researchers also found green tea beverages prevented other coronaviruses' infection as observed when tested against HCoV OC43 in HCT-8 cells.

Related Stories

  • Natural compound from pomegranate leaves shows promise against TTR amyloidosis
  • Heavy coffee drinking may weaken bone density in older women
  • COVID-19 initially reduced asthma attacks but widened socioeconomic disparities, study finds

The researchers next looked to see what was in green tea that was causing these antiviral effects. Catechins — EGCG, EGC, ECG, and EC — were studied because they are green tea’s active ingredients.

The results showed three catechins: EGCG, EGC, and ECG, dose-dependently blocked a pseudovirus infection caused by the wild-type SARS-CoV-2 strain.

Upon closer inspection, the researchers deduced EGCG as the most potent inhibitor for viral infection. EGCG makes up more than 50% of catechins found in green tea beverages.

In addition, exposing EGCG to mutated strains such as D614G, K417N, E484K, and N501Y suppressed its ability to cause infection.

The researchers also found EGCG inhibited viral infection of cells containing variants of concern, including B.1.17, B.1.351, and B.1.429.

EGCG was tested on infected human lung epithelial cells, where they discovered it could suppress SARS-CoV-2 before and after infection. Although, the inhibitory activity was greater when cells were pretreated with EGCG before SARS-CoV-2 infection.

Catechin’s antiviral activity was also effective in preventing infection from other related coronaviruses. EGCG was the most effective in suppressing HCoV OC43, while EC was the least effective.

EGCG prevents inhibition by blocking SARS-CoV-2 binding to ACE2 receptor

EGCG was most effective in stopping the viral entry of SARS-CoV-2 in human cells before infection — although it was also somewhat effective during infection.

The researchers found it blocked viral entry by preventing the S1 subunit — which has the highest binding affinity — to ACE2. EGCG also decreased binding of the S2 subunit, although it already had a little binding affinity to ACE2.

The researchers concluded:

We found that the recombinant RBD could bind to ACE2 with EC50 of 4.08 ng/mL, while EGCG significantly decreased the binding affinity of RBD (4.7-fold) with EC50 of 19.19 ng/mL. In addition, EGCG also diminished the binding affinity of full-length S to ACE2 by 2.5-fold (EC50: 43.48 to 107.6 ng/mL). The inhibitory effect of EGCG on RBD or full-length S binding to ACE2 was dose-dependent.”

This news article was a review of a preliminary scientific report that had not undergone peer-review at the time of publication. Since its initial publication, the scientific report has now been peer reviewed and accepted for publication in a Scientific Journal. Links to the preliminary and peer-reviewed reports are available in the Sources section at the bottom of this article. View Sources

Journal references:
  • Preliminary scientific report. Liu J, et al. Epigallocatechin Gallate from Green Tea Effectively Blocks Infection of SARS-CoV-2 and New Variants by Inhibiting Spike Binding to ACE2 Receptor. bioRxiv, 2021. doi: https://doi.org/10.1101/2021.03.17.435637, https://www.biorxiv.org/content/10.1101/2021.03.17.435637v1
  • Peer reviewed and published scientific report. Liu, Jinbiao, Brittany H. Bodnar, Fengzhen Meng, Adil I. Khan, Xu Wang, Sami Saribas, Tao Wang, et al. 2021. “Epigallocatechin Gallate from Green Tea Effectively Blocks Infection of SARS-CoV-2 and New Variants by Inhibiting Spike Binding to ACE2 Receptor.” Cell & Bioscience 11 (1). https://doi.org/10.1186/s13578-021-00680-8. https://cellandbioscience.biomedcentral.com/articles/10.1186/s13578-021-00680-8.

Article Revisions

  • Apr 6 2023 - The preprint preliminary research paper that this article was based upon was accepted for publication in a peer-reviewed Scientific Journal. This article was edited accordingly to include a link to the final peer-reviewed paper, now shown in the sources section.

Posted in: Medical Science News | Medical Research News | Disease/Infection News | Healthcare News

Comments (1) Jocelyn Solis-Moreira

Written by

Jocelyn Solis-Moreira

Jocelyn Solis-Moreira graduated with a Bachelor's in Integrative Neuroscience, where she then pursued graduate research looking at the long-term effects of adolescent binge drinking on the brain's neurochemistry in adulthood.

  • Download PDF Copy

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Solis-Moreira, Jocelyn. (2023, April 06). A green tea compound shows anti-SARS-CoV-2 properties in vitro. News-Medical. Retrieved on March 06, 2026 from https://www.news-medical.net/news/20210322/A-green-tea-compound-shows-anti-SARS-CoV-2-properties-in-vitro.aspx.

  • MLA

    Solis-Moreira, Jocelyn. "A green tea compound shows anti-SARS-CoV-2 properties in vitro". News-Medical. 06 March 2026. <https://www.news-medical.net/news/20210322/A-green-tea-compound-shows-anti-SARS-CoV-2-properties-in-vitro.aspx>.

  • Chicago

    Solis-Moreira, Jocelyn. "A green tea compound shows anti-SARS-CoV-2 properties in vitro". News-Medical. https://www.news-medical.net/news/20210322/A-green-tea-compound-shows-anti-SARS-CoV-2-properties-in-vitro.aspx. (accessed March 06, 2026).

  • Harvard

    Solis-Moreira, Jocelyn. 2023. A green tea compound shows anti-SARS-CoV-2 properties in vitro. News-Medical, viewed 06 March 2026, https://www.news-medical.net/news/20210322/A-green-tea-compound-shows-anti-SARS-CoV-2-properties-in-vitro.aspx.

Suggested Reading

Nearly 70 weeks after infection, long COVID patients show no detectable inflammation in blood testsNearly 70 weeks after infection, long COVID patients show no detectable inflammation in blood testsAdvancing brain microphysiological systems for in vitro neurotoxicity and cognitive function testingAdvancing brain microphysiological systems for in vitro neurotoxicity and cognitive function testingDual targeting strategy suppresses pancreatic cancer cell growthDual targeting strategy suppresses pancreatic cancer cell growthNewly discovered compound can advance the body's internal clockNewly discovered compound can advance the body's internal clockCOVID-19 ARDS survivors face lasting disability and high late mortality, researchers reportCOVID-19 ARDS survivors face lasting disability and high late mortality, researchers reportNew compound advances body clock independent of dosing timeNew compound advances body clock independent of dosing timeCOVID-19 severity is linked to changes in mitochondrial DNA methylationCOVID-19 severity is linked to changes in mitochondrial DNA methylationLarge Swedish study finds COVID-19 vaccination unrelated to fertility or childbirth ratesLarge Swedish study finds COVID-19 vaccination unrelated to fertility or childbirth rates

Comments

  1. Also, follow the bellow research article which was published in nature Atala Jena Atala Jena India says: March 27, 2021 at 12:45 AM

    Also, follow the bellow research article which was published in nature "scientific report" journal.https://www.nature.com/articles/s41598-021-81462-7

    0 0 Reply
The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical. Post a new comment (Logout) Quirky Comment Title Post

Sign in to keep reading

We're committed to providing free access to quality science. By registering and providing insight into your preferences you're joining a community of over 1m science interested individuals and help us to provide you with insightful content whilst keeping our service free.

Google Sign in with Google Apple Sign in with Apple LinkedIn Sign in with LinkedIn Facebook Sign in with Facebook or Email Sign in with email
  • TrendingStories
  • LatestInterviews
  • Top HealthArticles
  • Scientists put forward a new theory of brain developmentScientists put forward a new theory of brain development
  • Scientists discover how muscle stem cells "flip a switch" to rebuild damaged muscleScientists discover how muscle stem cells "flip a switch" to rebuild damaged muscle
  • New strategy targets Porphyromonas gingivalis without harming healthy microbesNew strategy targets Porphyromonas gingivalis without harming healthy microbes
  • Electrohydrodynamic bioprinting creates living muscle tissues with tightly aligned cells insideElectrohydrodynamic bioprinting creates living muscle tissues with tightly aligned cells inside
  • Study reveals hydration energetics as key to nanoparticle performance in medicineStudy reveals hydration energetics as key to nanoparticle performance in medicine

Exploring the nanoscale: How AFM is transforming cosmetic science

Alexander Dulebo

Discover how Bruker is helping drive innovation in cosmetic science through advanced AFM techniques.

Exploring the nanoscale: How AFM is transforming cosmetic science

Innovating Texture and Culture in Plant-Based Foods

Gabi Saavedra

Discover how Thermo Fisher is shaping the future of plant-based foods through texture innovation and cultural relevance.

Innovating Texture and Culture in Plant-Based Foods

Advancing brain microphysiological systems (bMPS)

Dr. Lena Smirnova

Brain microphysiological systems are reshaping in vitro neurotoxicity testing through functional validation and advanced disease modeling.

Advancing brain microphysiological systems (bMPS)
  • The Gut–Brain–Skin Axis: How Diet and Gut Health Influence Mood, Skin, and AgingThe Gut–Brain–Skin Axis: How Diet and Gut Health Influence Mood, Skin, and Aging
  • How the Menstrual Cycle Affects Appetite, Metabolism, and NutritionHow the Menstrual Cycle Affects Appetite, Metabolism, and Nutrition
  • Maternal Diet After Childbirth And Its Role In Postpartum RecoveryMaternal Diet After Childbirth And Its Role In Postpartum Recovery
  • Chrono-Cardiology and Chrononutrition: Integrating Circadian Biology Into Cardiometabolic CareChrono-Cardiology and Chrononutrition: Integrating Circadian Biology Into Cardiometabolic Care
  • The Science of Appetite Control: How Hormones Regulate Hunger and SatietyThe Science of Appetite Control: How Hormones Regulate Hunger and Satiety

Latest News

  • Surgical robot can help safely remove the caudate lobeSurgical robot can help safely remove the caudate lobe
  • Machine learning model may provide an earning warning of preeclampsia in late gestationMachine learning model may provide an earning warning of preeclampsia in late gestation
  • Scientists identify common molecular program across multiple brain tumor typesScientists identify common molecular program across multiple brain tumor types
  • Single dose of CAR-astrocyte therapy halves amyloid levels in mice brainsSingle dose of CAR-astrocyte therapy halves amyloid levels in mice brains
  • Researchers develop non-hormonal contraceptives to reduce side effects for couplesResearchers develop non-hormonal contraceptives to reduce side effects for couples

Newsletters you may be interested in

  • COVID-19 COVID-19 (Subscribe or Preview)
  • Cardiology Cardiology (Subscribe or Preview)
  • Infectious Diseases Infectious Diseases (Subscribe or Preview)
See all Newsletters » Azthena chat logo

Hi, I'm Azthena, you can trust me to find commercial scientific answers from News-Medical.net.

To start a conversation, please log into your AZoProfile account first, or create a new account.

Registered members can chat with Azthena, request quotations, download pdf's, brochures and subscribe to our related newsletter content.

Log in

A few things you need to know before we start. Please read and accept to continue.

  • Use of “Azthena” is subject to the terms and conditions of use as set out by OpenAI.
  • Content provided on any AZoNetwork sites are subject to the site Terms & Conditions and Privacy Policy.
  • Large Language Models can make mistakes. Consider checking important information.
I understand, and agree to receive occasional emails about Azthena such as usage tips and new feature announcements.

Please check the box above to proceed.

Start Chat

Great. Ask your question.

Clear Chat Clear Chat Brief Moderate Detailed

Azthena may occasionally provide inaccurate responses. Read the full terms.

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback

Submit Cancel You might also like... RSV and COVID-19 trigger different immune responses in infants

Tag » What Tea Is Good For Covid